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taking into account that as yet we do not know whether the two
definitions correlate.
The analysis of follow up data in GARP may reveal whether ge-
netic predisposition for a higher baseline serum CRP is causally
contributing to the development of hand OA.
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Purpose: Viruses have long been suspected to be involved in
the pathogenesis of rheumatic diseases. In the last years, an
increasing number of studies of viral DNA prevalences in blood,
serum and synovial fluid suggest the involvement of the viruses
in these diseases. Less numerous, but not less important, are
the studies carried out in bone marrow. In addition, total bone
marrow transplantation has been used for repairing of damaged
tissues in different pathological situations (i.e. osteogenesis im-
perfecta) and mesenchymal stem cells (MSCs) seem to be the
best candidates for cell therapy for regeneration of injured tissue.
Thus, the risk of viral transmission in bone marrow transplan-
tation or autologous MSCs transplantation could be a serious
problem.
The purpose of this study was to evaluate the importance of
viral infections in osteoarthritis (OA) through the measurement of
the prevalence and viral load of Parvovirus B19 (B19), Varicella-
zoster virus (VZV), and Human Herpesvirus-6 (HHV-6), in MSCs
from bone marrow of patients with OA and healthy donors.
Methods: A total of 18 patients with OA (mean age 74.7 years,
range 61-89) and 10 healthy donors with no known history of joint
disease (mean age 66.6, range 44-90) were recruited from the
Service of Orthopaedic Surgery of Hospital Clinico San Carlos.
Fresh bone marrow aspirates were obtained from the distal femur
of the patients with OA after total knee replacement surgery and
from healthy donors during tissue harvest in the process of mul-
tiorganic donation (n=3) or from proximal femur in the surgery for
the subcapital fracture of the hip (n=7). MSCs were established
from bone marrow aspirates of OA patients and healthy donors.
DNA was extracted from primary MSCs culture established from
these cells and quantitative real time polymerase chain reaction
was performed to analyse the prevalence and viral load of B19,
VZV and HHV-6. Differences between groups were analyzed us-
ing the two-tailed Student’s t test and the Mann-Whitney U test
for normal and non-normal quantitative variables respectively.
The Chi-square test was used to compare categorical variables.
A two-sided P value of 0.05 was the criterion for statistical
significance in all cases.
Results: We found a total viral DNA prevalence of 16.7% (3/18)
among OA patients: 1/18 was positive for B19, 2/18 for VZV, and
0/18 for HHV-6. In the control group, we found a total viral DNA
prevalence of 20% (2/10); the two positives belonged to B19. We
did not find any statistical significant difference.
Conclusions: This first approach to the viral prevalence in MSCs
of bone marrow in OA patients seem do not support the possible
involvement of the viruses in the pathophysiology of OA, and
show a very low risk of viral reactivation in a possible MSCs
transplantation.
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Purpose: Osteoarthritis (OA) is a complex disease of the skele-
ton and is associated with ageing. Both environmental and ge-
netic factors contribute to the pathogenesis. We here set out
to identify novel genes associated with OA, concentrating on
regulatory polymorphisms allowing for differential expression.
Methods: Our strategy included an initial transcriptome analy-
sis of the PBMC of 6 OA patients and 6 age-matched healthy
controls in order to identify differentially expressed genes. These
were screened for allelic expression imbalances and potentially
regulatory SNPs in the 5’regions of the genes. To establish
disease association, disparate promoter SNP distributions cor-
relating with the differential expression were tested on larger
cohorts.
Results: Our approach yielded 26 candidate genes differen-
tially expressed between patients and controls. While BLP2
and CIAS1 seem to be trans-regulated as suggested by the
absence of allelic expression imbalances, the presence of al-
lelic imbalances confirms cis-regulatory mechanisms for RHOB
and TXNDC3. Interestingly, on/off switching suggests additional
trans-regulation for TXNDC3. Moreover, we demonstrate statisti-
cally significant associations between 5’ SNPs and the disease
for RHOB and TXNDC3, hinting at regulatory functions.
Conclusions: Investigating the respective genes functionally will
not only shed light on the disease association but will also add
to the understanding of the pathogenic processes involved in OA
and may point out novel therapeutic approaches.
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Purpose: To explore the possibility that non-synonymous SNPs
altering conserved aminoacids of the main in vivo aggrecanase
could play a role in OA susceptibility. That ADAMTS5 (a disinte-
grin and metalloproteinase with thrombospondin motifs 5) is the
main aggrecasnase has been shown in knockout mouse models
of OA and of inflammatory arthritis where cartilage degradation
was prevented.
Methods: A case-control study has been done with samples
from Spain, the UK and Greece. Three groups of Spanish OA
patients were studied: with total joint replacement for primary OA
in the hip, THR (n = 310), or the knee, TKR (n = 277) or with
hand OA, HOA (n = 242). Samples form TKR patients from the
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UK (n = 352) and Greece (n = 157) were also studied. Controls
were selected to exclude clinical OA symptoms and were older
than 44 years (from Greece, n = 183), or of 54 years (from Spain,
n = 294, and the UK n = 454). Two ADAMTS5 non-synonymous
SNPs identified by the software SIFT as probably damaging the
enzyme function, rs226794 in exon 7 (P692L) and rs2830585 in
exon 5 (R614H), were studied.
Results: SNP R614H did not show allelic frequency differences
between controls and any of the three OA patient groups in the
Spanish sample collection and was not studied further. The minor
allele of SNP P692L, allele T, showed a trend to a decreased
frequency in Spanish TKR patients (11.5% vs 8.2% in controls,
p = 0.06). The Greek TKR samples did not show a significant
difference (9.8% in TKR vs 8.0% in controls), neither so the
UK TKR samples (10.9% in TKR vs 11.2% in controls). The
combined analysis did not show any effect of the P692L SNPs
(Mantel-Haenszel O.R. = 0.88, 95% C.I: 0.7-1.1, p = 0.25).
Conclusions: A first investigation of putative important SNPs in
the main in vivo aggrecanase, ADAMTS5, has failed to show any
relevant effect on OA susceptibility.
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Purpose: Osteoarthritis (OA) characterised by cartilage degra-
dation is a severe joint disorder affecting animals and humans
alike. Canine species provide a useful model to study this dis-
ease process as it mimics the human form of OA both clinically
and pathophysiologically. It has been proven that IL-1β and TNFα
are the inflammatory cytokines that accentuate the disease pro-
cess. The absence of Th2 cells in the inflammatory synovial fluid
points out that this disorder could be corrected by installing a
balance between the Th1 and Th2-response. Previous work has
shown that Interleukin 4 (IL-4) downregulates the inflammatory
pathway and therefore is a good candidate to combat OA in
canine species.
Methods: Present work focuses on simulating the OA disease
process in-vitro using canine chondrocytes in monolayer and 3D
cell culture systems. Our approach is based on dosage regulated
IL-4 expression under cell culture conditions. To achieve this we
are using promoter squelching as a method to self regulate
IL-4 expression involving the canine COX-2 promoter which we
partially sequenced.
Results: Our experiments have shown that canine chondrocytes
can be passaged till the 7th generation without any change in
morphology. We could also show by qPCR that these cells over
express inflammatory cytokines such as IL-6, IL-8 and IL-18 in
comparison to the house keeping gene GAPDH upon exogenous
stimulation with either human recombinant IL-1β or TNFα.
Conclusions: We report on the optimization of our canine in-
vitro model for OA therapy which includes IL-1β and TNFα
synthesis from canine PBMC as well as a reporter assay for
COX-2 promoter activity for our indigenously designed vector.
Efforts are on the way to increase expression levels of canine
IL-4 in cell culture.
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Purpose: Matrilin-3 is an extracellular matrix molecule showing
expression in growing skeletal tissues. Mutations in the matrilin-
3 gene (MATN3) are associated with mild forms of multiple
epiphyseal dysplasia and with hand osteoarthritis (hand OA).
Stefansson et al., 2003 identified a missense mutation (p.T303M)
in MATN3 (designated as SNP5) in a large cohort of patients from
Iceland which cosegregates with hand OA in several families. The
frequency of the mutant T allele is slightly more than 2% in the
Icelandic population and has a relative risk of 2.1. The aim of this
study was to replicate these recent findings in a German cohort
and to investigate a possible association with other forms of OA
Methods: We investigated 50 Caucasian patients with radio-
graphic and symptomatic hand OA of the first carpometacarpal
joint (CMC1), 176 Caucasian patients with radiographic and
symptomatic knee OA and 356 unrelated Caucasian control in-
dividuals from Germany. The genotyping of SNP5 and SNP6 in
the MATN3 gene (nomenclature as in Stefansson et al. 2003)
was performed by PCR amplification and subsequent cycle se-
quencing.
Results: Analysing the rare T allele of SNP5 we observed
expression in 10% of the hand OA patients (p = 0.00099) and
in 2.5% of healthy controls (p = 0.00670). The p-value remained
significant even after Bonferoni correction for multiple testing.
Thus, carriers of the T allele had an increased risk for developing
hand OA with an odds ratio of 4.28 (95% CI, 1.18-14.8). No
difference in allele frequency and no significant association could
be observed between this allele and the occurrence of knee OA
in our cohort (p = 0.85755). In contrast, the A allele of SNP6
did not show a significant difference in allele frequency in both
cohorts. The A allele was present in 30% of the hand OA patients
and in 40.5% of the control individuals, resulting in an odds ratio
of 0.63 (95% CI, 0.31-1.24), which exclude an association with
hand OA in our cohort. Also in the group of knee OA patients
there was no significant difference in the frequency of the A allele
as well as in the distribution of genotypes.
Conclusions: Our results support the importance of SNP5 for
this specific form of OA, but not for knee OA where no asso-
ciation could be found. These data are in accordance with the
published data from Stefansson et al., 2003 but in contrast to
the observation of Min et al., 2006. which could not verify the T
allele of SNP5 for an association with hand OA. This may be due
to variant diagnostic criteria or to the allele frequency difference
in the control group. However, further studies on the phenotype
correlation would help to clarify the role of matrilin-3 in cartilage
organisation.
